Ross Fasano, MD
Clinical Pathology/Laboratory Medicine · Atlanta, GANPI 1790951325
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Cerus Corporation at 41.1% of the total. Reporting peaked in 2022 at $11,928 and has fallen 80.0% since, to $2,385 in 2025.
Across 34 payments — averaging $858.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerus Corporation$12K
- Pfizer$9K
- Global Blood Therapeutics, Inc.$6K
- Immucor, Inc.$1K
- Terumo BCT, Inc.$749
- Tempus AI, Inc$30
- plus $24 from 1 others
Across 81 payments — averaging $16,768 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cerus Corporation$1.2M
- Terumo BCT, Inc.$150K
- Pfizer$4K
What the payments were for
- Consulting fees$6,27121%
- Speaking & faculty fees$10,22535%
- Travel & lodging$11,60640%
- Food & beverage$1,0504%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerus Corporation | 12 | $12,004 |
| Pfizer | 12 | $9,110 |
| Global Blood Therapeutics, Inc. | 2 | $6,271 |
| Immucor, Inc. | 1 | $1,000 |
| Terumo BCT, Inc. | 5 | $749 |
| Tempus AI, Inc | 1 | $30 |
| Foundation Medicine, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical pathology/laboratory medicine providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ferriprox (2 Times A Day)Deferiprone | 13 | $410,152 |
Paid to pharmacies, not to this prescriber.
Other clinical pathology/laboratory medicine in Atlanta
- Alexander DuncanAtlanta$73K
- James ZimringAtlanta$12K
- Cassandra JosephsonAtlanta$2K
- Charles HillAtlanta$171
- Robert AchramAtlanta$127
- Yuki HammersAtlanta$31
- Gurmukh SinghAugusta$19K
- Haohai LiangMarietta$146
- Brian WebberDecatur$77
- Craig CampusGainesville$49
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.